First, to confirm the role of GLS and MYC in prostate cancer progression, we have analyzed relative expression levels of these two genes in prostate cancer cells isolated from primary and metastatic tumor sites of the PC3 prostate cancer xenograft model as described previously 40, 41. The gene discussed is MYC; the disease is prostate carcinoma.